[1]
|
S. L. Hauser and A. K. Asbury, “Guillain-Barre Syndrome & Other Immune-Mediated Neuropathies,” In: 16th Edition, Harrison’s Principles of Internal Medicine, McGraw Hill, 2009, pp. 2667-2671.
|
[2]
|
A. A. Amato, “Guillain Barre Syndrome & Related Disorders,” Revista Mexicana de Neurociencia, Vol. 6, No. 5, 2005, pp. 455-469.
|
[3]
|
P. H. Gordon and A. J. Wilbourn, “Early Electrodiagnostic Findings in Guillain Barre Syndrome,” Archives of Neurology, Vol. 58, No. 6, 2001, pp. 913-917.
|
[4]
|
A. McGrogan, G. C. Madle, H. E. Seaman and C. S. de Vries, “The Epidemiology of Guillain-Barré Syndrome Worldwide—A Systematic Literature Review,” Neuroepidemiology, Vol. 32, No. 2, 2009, pp. 150-163.
doi:10.1159/000184748
|
[5]
|
M. Zaheer, M. Naeem and M. Nasrullah, “Seasonal Variation and Sex Distribution in Patients with Guillain-Barre Syndrome,” Pakistan Journal of Neurological Sciences, Vol. 3, No. 1, 2008, pp. 6-8.
|
[6]
|
A. Sharma, V. Lal, M. Modi, C. Vaishnavi and S. Prabhakar, “Campylobacter jejuni Infection in Guillain-Barré Syndrome: A Prospective Case Control Study in a Tertiary Care Hospital,” Neurology India, Vol. 59, No. 5, 2011, pp. 717-721. doi:10.4103/0028-3886.86547
|
[7]
|
M. A. Kannan, R. Kishore, S. A. Jabeen, K. R. Mridula, P. Rao and R. Borgohain, “Clinical, Electrophysiological Subtypes and Antiganglioside Antibodies in Childhood Guillain-Barré Syndrome,” Neurology India, Vol. 59, No. 5, 2011, pp. 727-732. doi:10.4103/0028-3886.86549
|
[8]
|
J. Meustec, F. G. A. Van Der Meche and the Dutch Guillain Barre Study Group, “Electrodiagnostic Criteria for Polyneuropathy and Demyelination: Application in 135 Patients with Guillain Barre Syndrome,” Journal of Neurology, Neurosurgery & Psychiatry, Vol. 59, No. 5, 1995, pp. 482-486. doi:10.1136/jnnp.59.5.482
|
[9]
|
S. Akbayram, M. Dogan, C. Akgün, E. Peker, R. Sayin and F. Aktar, “Clinical Features and Prognosis with Guillain-Barré Syndrome,” Annals of Indian Academy of Neurology, Vol. 14, No. 2, 2011, pp. 98-102.
doi:10.4103/0972-2327.82793
|
[10]
|
R. A. Hughes and J. H. Rees, “Clinical and Epidemiological Features of Guillain Barre Syndrome,” The Journal of Infectious Diseases, Vol. 176, No. 2, 1997, pp. S92S98. doi:10.1086/513793
|
[11]
|
T. W. Ho, B. Mishu, C. Y. Li, C. Y. Gao, D. R. Cornblath, J. W. Griffin, A. K. Asbury, M. J. Blaser and G. M. McKhann, “Guillain-Barré Syndrome in Northern China. Relationship to Campylobacter jejuni Infection and AntiGlycolipid Antibodies,” Brain, Vol. 118, No. 3, 1995, pp. 597-605. doi:10.1093/brain/118.3.597
|
[12]
|
C. J. Coe, “Guillain Barre Syndrome in Korean Children,” Yonsei Medical Journal, Vol. 30, No. 1, 1989, pp. 81-87.
|
[13]
|
S. V. Samad, R. M. Leila, H. Samaneh, D. Ghazaleh and H. Paria, “The Chronological Variation of Guillain Barre Syndrome (GBS) in North West of Iran,” Journal of Medical Sciences Research, Vol. 1, No. 3, 2011, pp. 19-24.
|
[14]
|
Z. Islam, B. C. Jacobs, M. B. Islam, Q. D. Mohammad, S. Diorditsa and H. P. Endtz, “High Incidence of GuillainBarré Syndrome in Children, Bangladesh,” Emerging Infectious Diseases, 2011.
doi:10.3201/eid1707.101999
|
[15]
|
A. B. Haghighi, M. A. Banihashemi, N. Zamiri, B. Sabayan, S. T. Heydari and A. Safari, “Seasonal Variation of Guillain-Barré Syndrome Admission in a Large Tertiary Referral Center in Southern Iran: A 10 Year Analysis,” Acta Neurologica Taiwanica, Vol. 21, 2012, pp. 60-6321.
|
[16]
|
R. K. Lyu, L. M. Tang, S. Y. Cheng, W. C. Hsu and S. T. Chen, “Guillain-Barré Syndrome in Taiwan: A Clinical Study of 167 Patients,” Journal of Neurology, Neurosurgery & Psychiatry, Vol. 63, No. 4, 1997, pp. 494-500.
doi:10.1136/jnnp.63.4.494
|
[17]
|
R. Van Koningsveld, R. Rico, I. Gerstenbluth, P. I. M. Schmitz, C. W. Ang and I. S. J. Merkies, “GastroenteritisAssociated Guillain-Barré Syndrome on the Caribbean Island Cura?ao,” Neurology, Vol. 56, No. 11, 2001, pp. 1467-1472. doi:10.1212/WNL.56.11.1467
|
[18]
|
K. Radhakrishnan, M. A. El-Mangoush and S. E. Gerryo, “Descriptive Epidemiology of Selected Neuromuscular Disorders in Benghazi, Libya,” Acta Neurologica Scandinavica, Vol. 75, No. 2, 1987, pp. 95-100.
doi:10.1111/j.1600-0404.1987.tb07901.x
|
[19]
|
S. J. Winner and J. Grimley Evans, “Age-Specific Incidence of Guillain-Barré Syndrome in Oxfordshire,” Oxford Journals of Medicine, Vol. 77, No. 3, 1990, pp. 1297-1304. doi:10.1093/qjmed/77.3.1297
|
[20]
|
S. Congia, M. Melis and M. A. Carboni, “Epidemiologic and Clinical Features of the Guillain-Barre Syndrome in Sardinia in the 1961-1980 Period,” Acta Neurologica (Napoli), Vol. 11, No. 1, 1989, pp. 15-20.
|
[21]
|
J. P. Larson, G. Kvale and H. Nyland, “Epidemiology of the Guillain-Barre Syndrome in the County of Hordaland, Western Norway,” Acta Neurologica Scandinavica, Vol. 71, No. 1, 1985, pp. 43-47.
doi:10.1111/j.1600-0404.1985.tb03165.x
|
[22]
|
V. Sivadon-Tardy, D. Orlikowski, F. Rozenberg, C. Caudie, T. Sharshar, P. Lebon, et al., “Guillain-Barré Syndrome, Greater Paris Area,” Emerging Infectious Diseases, Vol. 12, No. 6, 2006.
doi:10.3201/eid1206.051369
|
[23]
|
M. Louie, J. M. Gilchrist and C. Woodland, “Guillain Barre Syndrome: A 5 Year Rhode Island Hospital Experience,” Rhode Island Medicine, Vol. 77, 1994, pp. 135-140.
http://med.brown.edu/neurology/articles/ml13594.pdf
|
[24]
|
M. A. Arami, M. Yazdchi and R. Khandaghi, “Epidemiology and Characteristics of Guillain Barre Syndrome in the Northwest of Iran,” Annals of Saudi Medicine, Vol. 26, No. 1, 2006, pp. 22-27.
|
[25]
|
E. Storey, M. Cook, R. Peppard, H. Newton-John and E. Byrne, “Guillain-Barre Syndrome and Related Conditions in Victorian Teaching Hospitals 1980-1984,” Australian and New Zealand Journal of Medicine, Vol. 19, No. 6, 1989, pp. 687-693.
doi:10.1111/j.1445-5994.1989.tb00335.x
|
[26]
|
Z. Paolino, V. Govoni, M. R. Tola, I. Casetta and E. Granieri, “Incidence of the Guillain-Barre Syndrome in Ferrara, Northern Italy, 1981-1987,” Neuroepidemiology, Vol. 10, No. 3, 1991, pp. 105-111.
doi:10.1159/000110254
|
[27]
|
V. Govoni, E. Granieri, M. R. Tola, I. Casetta, P. Ruppi and L. Vaghi, “The Frequency of Clinical Variants of Guillain-Barre Syndrome in Ferrara, Italy,” Journal of Neurology, Vol. 246, No. 11, 1999, pp. 1010-1014.
doi:10.1007/s004150050505
|
[28]
|
M. J. Sedano, J. Calleja, E. Canga and J. Berciano, “Guillain-Barre Syndrome in Cantabria, Spain: An Epidemiological and Clinical Study,” Acta Neurologica Scandinavica, Vol. 89, No. 4, 1994, pp. 287-292.
doi:10.1111/j.1600-0404.1994.tb01682.x
|
[29]
|
E. Dias-Tosta and C. S. Kuckelhaus, “Guillain Barré Syndrome in a Population Less than 15 Years Old in Brazil,” Arquivos de Neuro-Psiquiatria, Vol. 60, No. 2B, 2002, pp. 367-373. doi:10.1590/S0004-282X2002000300005
|
[30]
|
D. Rebecca Prevots and R. W. Sutter, “Assessment of Guillain-Barre Syndrome Mortality and Morbidity in the United States: Implications for Acute Flaccid Paralysis Surveillance,” The Journal of Infectious Diseases, Vol. 175, No. 1, 1997, pp. S151-S155
doi:10.1093/infdis/175.Supplement_1.S151
|
[31]
|
M. Y. Yakoob, A. Rahman, B. Jamil and N. A. Syed, “Characteristics of Patients with Guillain Barre Syndrome at a Tertiary Care Centre in Pakistan, 1995-2003,” Journal of the Pakistan Medical Association, Vol. 55, No. 11, 2005, pp. 493-496.
|
[32]
|
Q. Cheng, D. S. Wang, G. X. Jiang, H. Han, Y. Zhang, W. Z. Wang and S. Fredrikson, “Distinct Pattern of AgeSpecific Incidence of Guillain-Barré Syndrome in Harbin, China,” Journal of Neurology, Vol. 249, No. 1, 2002, pp. 25-32. doi:10.1007/PL00007844
|